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José Ueleres Braga1,2*, Deborah Araújo da Conceição2 and Anete Trajman3,4Abstract
Background: The Brazilian National Tuberculosis Control Program (NTCP) recommended the fixed-dose four-drug
combination (FDC-RHZE) regimen to treat new tuberculosis cases in December 2009, expecting to increase
adherence and avoid resistance. We evaluated factors associated with the speed of the new regimen
implementation process in this continent-sized country.
Methods: We conducted an ecological study based on the Brazilian Case Notification Database (SINAN) having the
Brazilian municipalities as the analytical unit. Municipalities with at least one case reported from December 2009 to
March 2011 were considered eligible. The association of rapid (≤ 3 months) implementation of the new regimen
with demographic, epidemiological and operational health service characteristics, such as compliance with NTCP
recommendations (supervised treatment, bacteriological confirmation of the diagnosis and monthly bacteriological
monitoring), was analyzed. We used the adjusted odds ratios (OR) and their 95% confidence interval (CI) to assess
the association of independent variables with the outcome in a multiple logistic regression model.
Results: Rapid implementation of the new regimen in municipalities was associated with small populations
(OR=25.5, 95% CI= 19.1-34.1), low population density (OR=2.3, 95% CI= 1.9–2.9), low tuberculosis incidence rates
(OR=8.8, 95% CI= 6.7–11.4) and good compliance with other NTCP recommendations.
Conclusions: We showed that SINAN secondary data analysis is feasible and useful to learn lessons from.
Municipalities with high tuberculosis burden and large populations need special attention for implementing new
recommendations. This is particularly important considering the Global Alliance pipeline for new tuberculosis
treatment regimens.
Keywords: Tuberculosis, Drug combinations, Health plan implementation, Epidemiology, Public healthBackground
In 1996, the Brazilian National Tuberculosis Control Pro-
gram (NTCP) incorporated the directly observed treatment
strategy (DOTS) for reaching World Health Organization
(WHO) cure targets and reducing default rates, thus
preventing emergence of resistant bacillus [1]. In the follow-
ing years, as in other countries that recommended DOTS, a
decrease in default rates and an increment in case detection
and cure rates were observed in Brazil. Nevertheless, this* Correspondence: ueleres@gmail.com
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reproduction in any medium, provided the orwas insufficient to achieve the target for tuberculosis con-
trol in the country [2,3].
By the end of 2009, Brazil was the only high-burden
country to use a treatment regimen with only three drugs
[fixed-dose combination (FDC)-Rifampin and Isoniazid
(RH) and Pyrazinamide (Z)]. Despite a free-of-charge
treatment, the default rates were around 9.3%, attaining
14% in some states [4]. At this point, the NTCP advisory
board revised the Brazilian Tuberculosis Guidelines and
recommended the WHO-suggested four-drug FDC regi-
men for tuberculosis treatment for adolescents and adults
(over 10 years old). Besides including Ethambutol (E), the
new regimen reduced doses of H (from 400 to 300 mg)
and of Z (from 2000 to 1600 mg). The new FDC-RHZEtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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higher effectiveness of treatment. The rational was that
the smaller number of pills to be taken and the better tol-
erance due to dose reduction would increase adherence to
treatment [5]. Finally, the NTCP expected that the inclu-
sion of a fourth drug would fight the emergence of resist-
ance, which was, at that point, widely spread in Eastern
Europe, Asia and Africa [6].
According to the Brazilian Ministry of Health (MoH),
the implementation of the FDC-RHZE regimen has
followed a schedule set by the NTCP in agreement with
the Brazilian states’ programs [5]. The use of this regi-
men started in the North (Amazonian) region, which
had the highest incidence rate until the 90’s, while the
Southeast region, presently with the highest disease bur-
den, was the last one to implement the new regimen [7].
The effective use of the new regimen may have faced im-
portant barriers in healthcare services, such as poor ad-
hesion by professionals and by tuberculosis patients.
New tuberculosis treatment regimens and diagnostic
technologies in the health system are expected during
the following years [8-12]. Understanding the barriers
and bottlenecks that could delay the incorporation of
these technologies may be useful for the NTCP stake-
holders. In Brazil, several public health programs [8-12],
including DOTS [13], had their implementation process
investigated. However, no published studies on the im-
plementation process of the recently adopted therapeutic
regimen for tuberculosis were found in the literature.
The objective of the present study is to investigate socio-
demographic, epidemiological and operational factors asso-
ciated with the implementation process of the FDC-RHZE
regimen for tuberculosis treatment in Brazilian municipal-
ities. The understanding of this process may identify areas
with poor adhesion to the new intervention and eventually
guide the MoH in future implementation of health pro-
grams and policies in the country.
Methods
The analysis unit of this ecological study is the Brazilian
municipalities. Data from the Brazilian Case Notification
Database (SINAN-Tuberculosis) were used. All municipal-
ities with at least one tuberculosis case notified at SINAN
were considered eligible. Population size estimates were
those calculated by the Brazilian Geography and Statistics
Institute (IBGE) and are available on the Informatics De-
partment of the Brazilian National Health System’s website
(www.datasus.gov.br). Patient records from SINAN data-
base include which drugs were used but not the regimen
(i.e., whether FDC was in use). Thus, new adolescent and
adult (>10 years) cases notified between December 2009
and March 2011 using the four drugs (R, H, Z and E)
after the starting month of implementation of the FDC-
RHZE, as informed by the State Health Secretaries, wereconsidered as users of the new FDC-RHZE regimen. We
performed an initial quality evaluation on this data frame,
aiming to identify data completeness, errors and inconsist-
encies. We concluded that the database was adequate for
the present analysis [7].
The following epidemiological and demographic munici-
pal explanatory factors were analyzed: i- population size, ii-
population density and iii- tuberculosis incidence (absolute
number of cases and notification rate). Operational health
unit explanatory factors included other NTCP recommen-
dations [1]: i- use of directly observed treatment (DOT-), ii-
bacteriological confirmation of cases (positive sputum
smear or culture for M. tuberculosis) and iii- bacteriologic
monitoring of treated cases (monthly sputum smear). We
initially evaluated two outcomes: i- period of onset of the
new regimen implementation and ii- implementation
speed, i.e., the duration of time until maximum coverage
(100%) of the new regimen was reached. After an initial ex-
ploratory analysis with three ranges (≤2 months, 2–4
months and ≥ 4 months), we chose to work with a 3 month
cut-off. Rapid implementation was defined as up to three
months (≤3 months) from the onset to maximum coverage.
This period can be considered adequate for the Brazilian
health system based on its decentralized structure.
Exploratory data analysis also evaluated the distribu-
tion of the socio-demographic, epidemiological and op-
erational health service performance variables. We used
the odds ratio (OR) to compare the groups of interest.
We obtained crude and adjusted estimates in single and
multiple regression models using the STATA 10.0 soft-
ware [14]. The 95% confidence intervals (CI) was calcu-
lated using the Mantel-Hanszel method. Explanatory
variables with a marginal association with the outcome
(p≤0.20) in the bivariate analysis were included into the
multiple regression model.
This study was approved by the Institutional Review
Board of the Social Medicine Institute (process n°
0024.0.259.000-11) and by the National Committee of
Ethics in Research (CONEP, process n°16776).Results
The municipalities’ characteristics are described in
Table 1. Sixty-nine percent (3,826) of Brazilian munici-
palities were included. Over 70% implemented the new
regimen between the 4th quarter of 2009 and the 1st
quarter of 2010; 45% reached maximum coverage in less
than two months (Table 1).
Few municipalities (2%) have more than 250,000 in-
habitants, one-fifth have a high population density (over
88 inhabitants per km2) and the same proportion has a
density lower than 11 inhabitants per km2.
Most of the municipalities had a low or intermediate in-
cidence rate. Noteworthy, more than 90% of municipalities
Table 1 Characteristics of the municipalities that
implemented the FDC-RHZE regimen in Brazil
Characteristics n %
Time to achieve maximum coverage by the FDC-RHZE
regimen
Less than 2 months 1722 45.0
2 to 4 months 599 15.7
More than 4 months 1505 39.3
Period of onset of the FDC-RHZE regimen implementation
4th quarter 2009 to 1st quarter 2010 2734 71.5
2nd quarter 2010 to 3rd quarter 2010 734 19.2
4th quarter 2010 to 1st quarter 2011 358 9.3
Population of municipalities
Less than 10,000 inhabitants 1062 27.8
10,000-50,000 inhabitants 2156 56.3
50,000-250,000 inhabitants 509 13.3
250,000-500,000 inhabitants 61 1.6
More than 500,000 inhabitants 38 1.0
Classification of the population density
Less than 11 inhabitants/km2 817 21.4
11-22 inhabitants/km2 736 19.2
22-44 inhabitants/km2 906 24.0
44-88 inhabitants/km2 609 16.0
More than 88 inhabitants/km2 755 19.4
Level of incidence
Very low < 10/100,000 523 13.7
Low 10-25/100,000 1081 28.2
Intermediate 25-50/100,000 1329 34.7
High 50-100/100,000 667 17.4
Very high >100/100,000 226 6.0
Proportion of cases in DOT*
Very low <20% 114 3.0
Low 20-40% 36 1.0
Intermediate 40-60% 55 1.4
High 60-80% 88 2.3
Very high >80% 3533 92.3
Laboratory confirmation of diagnosis
Very low <20% 574 15.0
Low 20-40% 323 8.4
Intermediate 40-60% 672 17.5
High 60-80% 784 20.5
Very high >80% 1473 38.6
Laboratory monitoring
Very low <20% 983 25.7
Low 20-40% 310 8.2
Intermediate 40-60% 567 14.8
High 60-80% 633 16.5
Very high >80% 1333 34.8
* DOT- Directly observed treatment.
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under DOT (Table 1).
Over half of the municipalities perform laboratory
confirmation for tuberculosis in more than 60% of diag-
nosed cases. As for laboratory monitoring of treated
cases, 34% perform in less than 40% of cases and a simi-
lar proportion in more than 80% of cases (Table 1).
Because the onset date of implementation did not have
a clear trend, and no relationship was detected between
the explanatory factors and the onset of the implementa-
tion (data not shown), only rapid implementation was
analyzed as the outcome in the present study.
Table 2 presents demographic, epidemiological and
operational performance characteristics according to the
time to reach maximum coverage of the new RHZE-
FDC regimen. The more populated the municipalities
are, the longer it takes to reach maximum coverage.
Conversely, the higher the demographic density and in-
cidence rates, the slower the implementation. Based on
this exploratory analysis, the cut-off points of the inde-
pendent variables were set as shown in Table 3.
Operational health service performance characteristics,
such as more laboratory confirmation and monitoring of
cases, were associated with a more rapid implementation.
However, the inverse relationship occurs for the propor-
tion of cases under DOT (Table 2). In the multivariate
context, the association between speed and laboratory
monitoring has lost statistical significance (Table 3). The
variable “high laboratory monitoring (>80%)” was not as-
sociated in the multiple regression analysis. Thus, it was
excluded from the final model.
Discussion
The understanding of the process of adoption of any new
health technology becomes highly important for tubercu-
losis services as new diagnostic tests [15], treatment regi-
mens [16] and vaccines [17] are expected to emerge in the
next few years, after decades of stagnation. How to evalu-
ate these processes, however, is a challenge. Habicht et al.
(1999) [18] revised the design options to evaluate public
health program performance. They enumerate, as indica-
tors of performance: adequacy, provision, utilization,
coverage and impact. The authors also point out that spe-
cific interventions should be evaluated considering the ini-
tially planned implementation schedule. In the present
study, we chose to analyze the time till full coverage of the
implementation of a new treatment recommendation in
different municipalities in Brazil using secondary data.
This was only possible because notification of tuberculosis
is mandatory in the country.
Elmahalli et al. (2010) [19] assessed the implementation
of DOTS strategy in two chest facilities in Alexandria,
Egypt, using treatment success as the outcome. They
argue that operational indicators, such as treatment
Table 2 Epidemiological characteristics and NTP performance according to the time to full implementation of the FDC-
RHZE regimen in Brazil
Characteristics Time to full implementation of FDC-RHZE regimen in Brazil
Less than 2 months 2 to 4 months More than 4 months Total
Demographic and epidemiological
Size population (mean) 11756 17941 98974 47032
Population density (mean) 35.2 46.4 313.2 146.4
Tuberculosis incidence rate* 2010 (mean) 25.3 32.2 67.3 42.9
Operational NTP**
Proportion of patients with DOT*** (mean) 96.4 95.5 92.4 94.7
Proportion of patients with confirmatory laboratory tests (mean) 60.6 62.7 64.6 62.5
Proportion of patients with follow-up laboratory tests (mean) 49.6 59.0 59.6 55.0
* Rate per 100 hundred inhabitants; **NTP-National tuberculosis program; ***DOT-directly observed treatment.
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the process of tuberculosis care, especially in developing
countries. Although we agree that these are useful indica-
tors of program performance, they are less appropriate to
study the implementation process of a new recommenda-
tion. In our study, we preferred, instead, to study the im-
plementation process of the new treatment regimen using
a different approach, since other relevant data were avail-
able in the Brazilian surveillance system.
The implementation of new tuberculosis treatments,
including MDR-TB treatment, was reported in differentTable 3 Factors associated with a short time (≤ 3 months) to
Factors Crude odds ratio
Small population (< 10,000)
No 1
Yes 16.84
Low population density (<88 inhabitants /km2)
No 1
Yes 5.64
Low level of incidence TB (<50/100,000)
No 1
Yes 4.21
High coverage DOT* (>80%)
No 1
Yes 2.30
High laboratory confirmation pulmonary TB (>80%)
No 1
Yes 2.12
High laboratory monitoring (>80%)
No 1
Yes 1.45
Less than 120 patients treated
No 1
Yes 134.26
* DOT- Directly observed treatment.countries [20]. However, these analyses were essentially
descriptive. To our knowledge, there are no previous
studies addressing factors associated with the implementa-
tion process measured as the time to reach full coverage.
In the present study, we addressed the factors associated
with the time to full coverage of new regimen implemen-
tation process. Almost 70% of Brazilian municipalities had
notified at least one case of tuberculosis in the study period,
which reflects on one hand, the extent of the disease in the
country and on the other hand, the expansion of tubercu-
losis diagnostic activities. Demographic and epidemiologicalfull implementation of the FDC-RHZE regimen in Brazil
95% CI Adjusted odds ratio 95% CI
1
13.39 – 21.17 25.52 19.09- 34.10
1
4.68 – 6.80 2.33 1.87 – 2.91
1
3.57 – 4.96 8.79 6.75 – 11.45
1
1.79 – 2.95 1.55 1.14 – 2.12
1
1.85 – 2.42 1.93 1.63 – 2.29
1
1.27 – 1.67 0.92 0.78 – 1.09
1
18.73 – 962.41 10.07 1.36 – 74.52
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plementation. Among them, demographic factors had the
higher magnitude of association. Municipalities characteris-
tics such as population size, demographic density and inci-
dence rates were associated with the rapid implementation
of the new regimen. Although in a smaller magnitude,
compliance to some NTCP recommendations, such as
DOT and microbiological confirmation of cases, also were
associated with rapid implementation.
Larger municipalities generally have health systems with
many facilities, which need more human resources and
health infrastructure, more complex public health pro-
gram management. They also have populations with a
high heterogeneity concerning access to diagnosis and tu-
berculosis treatment services, which may explain the more
rapid implementation in smaller municipalities. This ex-
planation is corroborated by a recent study in Recife, a
large city in the Northeast of Brazil, where the incomplete
implementation of the epidemiological surveillance man-
agement was explained by lack of human resources and
incipient performance of planning and Monitoring &
Evaluation activities [21]. Likewise, the Family Health Pro-
gram implementation in Santa Catarina, a wealthy and de-
veloped state in Southern Brazil, was firstly implanted in
areas less assisted, in small or medium size municipalities,
where financial incentive to the program induced rapid
implementation. Indeed, one or two family health teams
offers high coverage rates in municipalities with up to
10,000 inhabitants [22].
Regardless of the population size, demographic density
also delayed the implementation of the new treatment.
Poor social condition found in situations of intense
urban agglomerations possibly hamper access to health
services. It is intuitive to expect that municipalities with
small populations or a small number of cases have easier
access to new regimens. Areas with large number of
cases demand more health units and higher number of
trained professionals. On the other hand, higher inci-
dence rates are usually found in situations of worse
health policy performance. Lack of professionals, trans-
port problems and insufficient resources for technical
assistance were considered the major barriers for tuber-
culosis control in São José do Rio Preto, a medium size
municipality [22].
In the present study, operational indicators such as
DOT coverage and microbiological confirmation of diag-
nosis, as recommended by the NTCP guidelines, were in-
dependently associated to rapid implementation of the
new regimen. This may reflect willingness, commitment
and capacity of municipal TCP in lining-up with new rec-
ommendations from the NTCP. None of those different
operational aspects represent by themselves a construct
regarding the quality of tuberculosis control actions prac-
ticed at the municipal level. However, the independentassociation of those factors indicates that they evaluate
different aspects of the same commitment.
Other factors possibly associated with rapid implementa-
tion of the new regimen, mainly those related to health ser-
vice organization (human resources, decentralization of
care, municipal tuberculosis control program structure
among others), were not considered due to the nature of
this study, which used secondary data from the tuberculosis
surveillance system. The quality of this database may have
influenced the results of this study. Thus, a previous evalu-
ation was done to ensure the quality of the data [7]. Other
possible limitations of this study may result from classifica-
tion of individuals regarding the use of the new regimen,
which was based on the use of 4 drugs in new cases, instead
of the use of FDCs, since the latter information is not avail-
able. This may have overestimated the coverage of the new
regimen, but is not likely to have influenced the evaluation
of the implementation speed.
Conclusions
The analysis of the Brazilian surveillance secondary data-
base made possible the evaluation of the implementation
process of a new tuberculosis treatment regimen in this
continental-sized country, measured by the length of
time to reach full coverage. This analytical approach is
useful to learn lessons. It was possible to demonstrate
that demographic and operational characteristics of mu-
nicipalities have influenced the implementation process.
Municipalities with larger population size, higher demo-
graphic density and higher incidence rates may need
more attention for the implementation of future new
guidelines for tuberculosis control as well as for other
diseases. Effectiveness studies are necessary and may be
performed using the same methodology.
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